Our Team

image193

Christine McSherry

Christine McSherry founded Jett Foundation in 2001, when her son now 24-year-old Jett was diagnosed with Duchenne Muscular Dystrophy. As head of the Jett Foundation, Christine co-founded the International Duchenne Alliance, a partnership of over 40 independent organizations that has funded nearly $15 million dollars in research to date. Christine has advocated for the patient perspective to be considered by the FDA when reviewing safe and potentially effective treatments for Duchenne. In April of 2016, Christine presented the Jett Foundation's Patient Centered Outcomes report at the FDA's meeting of the Peripheral and Central Nervous System Drugs Advisory Committee. 

image194

Mindy Leffler

Mindy's background in project management, software development, and information architecture came in handy when designing a PRO program for her son, Aidan, a 14-year-old with Duchenne Muscular Dystrophy. That PRO program then proved instrumental in the approval of EXONDYS51, the first FDA-approved treatment for Duchenne. When Aidan's insurance company denied coverage for EXONDYS, the data Mindy captured overturned the denial in 24 hours without engaging in the appeal process.

image195

Marielle Goyette

Marielle Goyette

Marielle Goyette

Director of Outcome Measure Development

image196

John Campbell

Marielle Goyette

Marielle Goyette

Director of Operations

image197

Snehal Pitake

Marielle Goyette

Snehal Pitake

Director of Quality

image198

Sonya Elder

Megan Hefner

Megan Hefner

Research Scientist

image199

Megan Hefner

Megan Hefner

Megan Hefner

Study Manager

image200

Sonja Hoven

Megan Hefner

Sonja Hoven

Study Coordinator

image201

John Hall

Kristina Davis

Kristi Byrne

Clinical Operations Consultant

image202

Kristi Byrne

Kristina Davis

Kristi Byrne

Director of Finance

image203

Kristina Davis

Kristina Davis

Kristina Davis

Director of Research